http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009507891-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1277
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-02
filingDate 2006-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2009-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2009507891-A
titleOfInvention Antibacterial formulation containing octenidine dihydrochloride encapsulated in liposomes
abstract [0063] The present invention relates to an antibacterial preparation comprising octenidine dihydrochloride in liposomes. The invention additionally relates to a method for producing a formulation and the use of phospholipids for producing an antimicrobial formulation comprising octenidine dihydrochloride. The formulation exhibits low cytotoxicity.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011513266-A
priorityDate 2005-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003508127-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S63126820-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001505552-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421227023
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID63417
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415727268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19871799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21414
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID63417
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID880643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453116950
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452708522
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23672301
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420306761
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID880643
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421328696
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551227

Total number of triples: 56.